Ersöz G et al. |
Effect of submaximal and incremental upper extremity exercise on platelet function and the role of blood shear stress. |
2002 |
Thromb. Res. |
pmid:12676189
|
Svensson J and Samuelsson K |
Inhibition of platelet function by low dose acetylsalicylic acid in patients with cerebrovascular disease. |
1983 |
Thromb. Res. |
pmid:20218005
|
Takasaki W et al. |
Superiority of plasma 11-dehydro-TXB2 to TXB2 as an index of in vivo TX formation in rabbits after dosing of CS-518, a TX synthase inhibitor. |
1993 |
Thromb. Res. |
pmid:8367836
|
Bradlow BA and Chetty N |
Dosage frequency for suppression of platelet function by low dose aspirin therapy. |
1982 |
Thromb. Res. |
pmid:7123514
|
Buchanan MR et al. |
Aspirin inhibits platelet function independent of the acetylation of cyclo-oxygenase. |
1982 |
Thromb. Res. |
pmid:7071811
|
Mikashima H and Muramoto Y |
Protective effect of Y-20811, a long-lasting thromboxane synthetase inhibitor, on endotoxin shock in rabbits. |
1990 |
Thromb. Res. |
pmid:2326771
|
Agren JJ et al. |
Dose responses in platelet fatty acid composition, aggregation and prostanoid metabolism during moderate freshwater fish diet. |
1990 |
Thromb. Res. |
pmid:2326774
|
Pedersen AK et al. |
Inhibition of thromboxane biosynthesis in serum: limitations of the measurement of immunoreactive 6-keto-PGF1 alpha. |
1984 |
Thromb. Res. |
pmid:6546456
|
Grauso F et al. |
Effects of iloprost (ZK 36374), a prostacyclin derivative, on platelet function after ischaemic exercise in patients with stable angina pectoris. |
1987 |
Thromb. Res. |
pmid:2447664
|
Udvardy M et al. |
Plasma thromboxane and prostacyclin metabolite ratio in atherosclerosis and diabetes mellitus. |
1987 |
Thromb. Res. |
pmid:3116717
|
Cholette JM et al. |
Aspirin resistance following pediatric cardiac surgery. |
2010 |
Thromb. Res. |
pmid:20550971
|
Umemura K et al. |
Effect of dietary docosahexaenoic acid in the rat middle cerebral artery thrombosis model. |
1995 |
Thromb. Res. |
pmid:7660354
|
GarcÃa Frade LJ et al. |
Diabetes mellitus as a hypercoagulable state: its relationship with fibrin fragments and vascular damage. |
1987 |
Thromb. Res. |
pmid:3118498
|
Davì G et al. |
Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-independent diabetics. |
1982 |
Thromb. Res. |
pmid:6761893
|
Cerskus AL et al. |
Effects of indomethacin and sulfinpyrazone on in vivo formation of thromboxane B2 and prostaglandin D2 during arachidonate infusion in rabbits. |
1978 |
Thromb. Res. |
pmid:653641
|
Rousson D et al. |
Acute myocardial infarction: measurement of arachidonate end-products in whole blood as an index of platelet cyclo-oxygenase activity in vivo. |
1987 |
Thromb. Res. |
pmid:3122356
|
Gachályi B et al. |
In vitro effect of cimetidine on ADP induced platelet aggregation and thromboxane A2 synthesis in man. |
1984 |
Thromb. Res. |
pmid:6474407
|
Fitzpatrick F et al. |
Development of a gas chromatographic-mass spectrometric method using a stable isotope internal standard for quantitation of thromboxane B2. |
1984 |
Thromb. Res. |
pmid:6474413
|
Lukasik M et al. |
Aspirin treatment influences platelet-related inflammatory biomarkers in healthy individuals but not in acute stroke patients. |
2011 |
Thromb. Res. |
pmid:21788065
|
Ali M et al. |
Synthesis of prostaglandin D2 and thromboxane B2 by human platelets. |
1977 |
Thromb. Res. |
pmid:918907
|
Reis F et al. |
The peripheral serotonergic system and platelet aggregation in cyclosporin A-induced hypertensive rats. |
1999 |
Thromb. Res. |
pmid:10605951
|
Tindall H et al. |
Thrombin generation precedes platelet activation in native blood taken from the hand during multiple blood sampling following cold challenge. |
1987 |
Thromb. Res. |
pmid:3617016
|
Mannucci L et al. |
Indobufen is a potent inhibitor of whole blood aggregation in patients with a high atherosclerotic risk. |
1987 |
Thromb. Res. |
pmid:3445229
|
Jørgensen KA et al. |
The survival of pig to rabbit renal xenografts during inhibition of thromboxane synthesis. |
1983 |
Thromb. Res. |
pmid:6364449
|
Naran NH and Chetty N |
The in vitro effect of ridogrel on platelet function in normocholesterolaemic and familial hypercholesterolaemic type IIa subjects. |
1997 |
Thromb. Res. |
pmid:9556227
|
Franconi F et al. |
Effect of gamma-hydroxybutyric acid on human platelet aggregation in vitro. |
2001 |
Thromb. Res. |
pmid:11369419
|
Todd MH et al. |
The involvement of prostaglandins and thromboxanes in the response to pulmonary embolism in anaesthetized rabbits and isolated perfused lungs. |
1983 |
Thromb. Res. |
pmid:6687961
|
|
Platelet function during long-term treatment with ketanserin of claudicating patients with peripheral atherosclerosis. A multi-center, double-blind, placebo-controlled trial. The PACK Trial Group. |
1989 |
Thromb. Res. |
pmid:2528841
|
Di Minno MN et al. |
Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis. |
2011 |
Thromb. Res. |
pmid:21669453
|
Ames PR et al. |
Aspirin insensitive thromboxane generation is associated with oxidative stress in type 2 diabetes mellitus. |
2012 |
Thromb. Res. |
pmid:22521214
|
Togna GI et al. |
Cisplatin triggers platelet activation. |
2000 |
Thromb. Res. |
pmid:10973681
|
Vesterqvist O et al. |
In vivo production of thromboxane in acute human myocardial infarction: a preliminary study. |
1985 |
Thromb. Res. |
pmid:3992528
|
Kelton JG et al. |
A study of the bioavailability and platelet inhibitory effects of a new enteric-coated acetylsalicylic acid preparation. |
1984 |
Thromb. Res. |
pmid:6740573
|
Chou TC et al. |
The inhibitory effect of 2-thienyl 2'-hydroxyphenyl ketone (C85) on platelet thromboxane formation. |
1996 |
Thromb. Res. |
pmid:8897698
|
Schmid P et al. |
Passive smoking and platelet thromboxane. |
1996 |
Thromb. Res. |
pmid:8907294
|
Preston FE et al. |
Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man. |
1982 |
Thromb. Res. |
pmid:6815823
|
Pinto S et al. |
No signs of increased thrombin generation in menopause. |
1990 |
Thromb. Res. |
pmid:2201101
|
De Caterina R et al. |
Long-term maintenance of thromboxane inhibition by two different aspirin regimens in patients with unstable angina. |
1990 |
Thromb. Res. |
pmid:2126400
|
De La Cruz JP et al. |
Effect of DT-TX 30, a combined thromboxane synthase inhibitor and thromboxane receptor antagonist, on retinal vascularity in experimental diabetes mellitus. |
2000 |
Thromb. Res. |
pmid:10680643
|
Weber AA et al. |
40 mg of aspirin are not sufficient to inhibit platelet function under conditions of limited compliance. |
2000 |
Thromb. Res. |
pmid:10709913
|
Wu TM et al. |
Inhibitory effect of hexapeptide (RGRHGD) on platelet aggregation. |
2000 |
Thromb. Res. |
pmid:10674405
|
Leoncini G et al. |
In retinal vein occlusion platelet response to thrombin is increased. |
2009 |
Thromb. Res. |
pmid:19660790
|
Küster LJ and Frölich JC |
PAF-induced platelet aggregation and TXB2 formation. |
1989 |
Thromb. Res. |
pmid:2922704
|
Carter AJ and Jones EW |
The effect of the degree of diabetic control on thromboxane synthesis in clotted whole blood. |
1986 |
Thromb. Res. |
pmid:3515613
|
Neiman J et al. |
Platelet uptake of serotonin (5-HT) during ethanol withdrawal in male alcoholics. |
1987 |
Thromb. Res. |
pmid:2820078
|
Altman R et al. |
Why single daily dose of aspirin may not prevent platelet aggregation. |
1988 |
Thromb. Res. |
pmid:3140408
|
De la Cruz JP et al. |
Effect of erythrocytes and prostacyclin production in the effect of fructose and sorbitol on platelet activation in human whole blood in vitro. |
1997 |
Thromb. Res. |
pmid:9219331
|
Weigel G et al. |
Regulation of eicosanoid release in human umbilical endothelial cells. |
1991 |
Thromb. Res. |
pmid:1656543
|
Delvos U et al. |
Direct radioimmunological measurement of thromboxane B2 in plasma. |
1985 |
Thromb. Res. |
pmid:4082109
|
Ko FN et al. |
Antiplatelet effects of protopine isolated from Corydalis tubers. |
1989 |
Thromb. Res. |
pmid:2559491
|